Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
This quick guide shows Which Index Funds Are Tax Efficient 2024 and the key factors to compare for better after-tax outcomes.
24,458 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
China accelerates grid expansion to channel renewables and cut imports, a move shaping energy costs and bond markets ...
The AI revolution is just getting started, and a few names stand out as strong, long-term bets. This guide highlights...
Home listings are cooling fast as sellers reset prices. The latest data show a record decline in home asking prices, ...
A mid-size fund reduced its TriMas stake by about $5 million after a strong run, but didn’t exit the position entirel...
Treasury Secretary Scott Bessent dismissed fears of runaway oil prices as Middle East tensions persist, insisting the...
House appropriators moved a fiscal 2027 THUD bill that preserves key housing programs but hints at reductions elsewhe...
A Scattered Spider suspect extradited to the US shines a light on how cross-border cybercrime prosecutions unfold. Th...
Trilogy Metals stock tanked after a tepid earnings release, shaking confidence in a company that explores copper, gol...
Meta Platforms is ending Horizon Worlds as a standalone VR social platform and redirecting capital to AI infrastructu...
Three heavyweights are quietly reshaping how money moves across borders. Ripple, SWIFT and Visa are testing new rails...
Russia is moving toward a broader embrace of its digital ruble, with key banks and merchants prepared to accept it by...